|Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies …|
L Cooley, C Dendle, J Wolf, BW Teh, SC Chen, C Boutlis, KA Thursky
Internal medicine journal 44 (12b), 1350-1363, 2014
|Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance|
R Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, ...
Medical Journal of Australia 212 (10), 481-489, 2020
|Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy|
BW Teh, SJ Harrison, LJ Worth, T Spelman, KA Thursky, MA Slavin
British journal of haematology 171 (1), 100-108, 2015
|Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines|
KL Flanagan, E Best, NW Crawford, M Giles, A Koirala, K Macartney, ...
Frontiers in immunology, 2410, 2020
|Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies|
BW Teh, JC Teng, K Urbancic, A Grigg, SJ Harrison, LJ Worth, MA Slavin, ...
Haematologica 100 (1), e28, 2015
|Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection|
BW Teh, SJ Harrison, M Pellegrini, KA Thursky, LJ Worth, MA Slavin
Blood Reviews 28 (2), 75-86, 2014
|Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies|
BW Teh, CS Tam, S Handunnetti, LJ Worth, MA Slavin
Blood reviews 32 (6), 499-507, 2018
|Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs|
K Thursky, S Lingaratnam, J Jayarajan, GM Haeusler, B Teh, M Tew, ...
BMJ open quality 7 (3), e000355, 2018
|Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis|
BW Teh, SJ Harrison, LJ Worth, KA Thursky, MA Slavin
European Journal of Cancer 67, 21-37, 2016
|Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic|
B Teh, K Olsen, J Black, AC Cheng, C Aboltins, K Bull, PDR Johnson, ...
Scandinavian journal of infectious diseases 44 (4), 289-296, 2012
|Epidemiology of invasive fungal disease in lymphoproliferative disorders|
JC Teng, MA Slavin, BW Teh, SM Lingaratnam, MR Ananda-Rajah, ...
Haematologica 100 (11), e462, 2015
|Late‐onset Pneumocystis jirovecii pneumonia post–fludarabine, cyclophosphamide and rituximab: implications for prophylaxis|
GM Haeusler, MA Slavin, JF Seymour, S Lingaratnam, BW Teh, CS Tam, ...
European journal of haematology 91 (2), 157-163, 2013
|Azole antifungals and new targeted therapies for hematological malignancy|
J Lindsay, BW Teh, K Micklethwaite, M Slavin
Current Opinion in Infectious Diseases 32 (6), 538-545, 2019
|Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer …|
BW Teh, LJ Worth, SJ Harrison, KA Thursky, MA Slavin
Supportive Care in Cancer 23 (7), 1901-1906, 2015
|Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia|
B Teh, ML Grayson, PDR Johnson, PGP Charles
Clinical Microbiology and Infection 18 (4), E71-E73, 2012
|Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study|
AIT Hebbard, MA Slavin, C Reed, JA Trubiano, BW Teh, GM Haeusler, ...
Supportive Care in Cancer 25 (6), 1923-1930, 2017
|Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization|
BW Teh, MA Slavin, SJ Harrison, LJ Worth
Expert review of anti-infective therapy 13 (11), 1325-1336, 2015
|Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing|
SA Sim, VKY Leung, D Ritchie, MA Slavin, SG Sullivan, BW Teh
Biology of Blood and Marrow Transplantation 24 (7), 1490-1496, 2018
|Disseminated Scedosporium prolificans infection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics|
JA Trubiano, E Paratz, M Wolf, BW Teh, M Todaro, KA Thursky, MA Slavin
Mycoses 57 (9), 572-576, 2014
|CAR-T cell therapy and infection: a review|
O Bupha-Intr, G Haeusler, L Chee, K Thursky, M Slavin, B Teh
Expert Review of Anti-infective Therapy 19 (6), 749-758, 2021